<a href="https://laohu8.com/S/SLDB">Solid Biosciences</a> Inc. Announces $85 Million Common Stock Offering Under New Prospectus Supplement
Solid Biosciences Inc. has announced the filing of a prospectus supplement related to the offer and sale of up to $85 million in common stock shares. This move is part of an amended sales agreement with Jefferies LLC. Previously, the company had issued and sold shares for gross proceeds of approximately $10.5 million under a prior prospectus. Legal counsel from Wilmer Cutler Pickering Hale and Dorr LLP has provided a legal opinion on the shares, ensuring compliance with applicable registration requirements.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solid Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-072792), on May 15, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。